The AML Channel

Explore the latest updates, including expert interviews, features, podcasts and e-learning

The AML Channel on VJHemOnc is supported by Curis Inc., Pfizer, GlycoMimetics and Jazz Pharmaceuticals The supporters have no influence over the production of the content.

Welcome to The Acute Myeloid Leukemia (AML) Channel

VJHemOnc brings you the latest and greatest global advances related to the classification, diagnosis, treatment, and management of AML. Speaking with world-leading experts, The AML Channel delivers video interviews, podcasts, roundtable discussions and more.

Hot topics frequently covered on The AML Channel include the use of measurable residual disease (MRD) testing to guide treatment, antibody-based treatments and CAR-T cell therapies.

Conferences

SOHO Italy 2022
SOHO 2022
EHA 2022
ASCO 2022
Tandem Meetings 2022
BSH 2022

Topics

MRD
Transplant
CAR-T & Cellular Therapy
Real-World Data
Trial Updates
Immuno-Oncology

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter